title: Lichen striatus associated with etanercept treatment of rheumatoid arthritis.
authors.affiliation: Division of Dermatology, San Gallicano Dermatological Institute, Rome, Italy.
authors.forename: Viviana
authors.initials: V
authors.lastname: Lora
authors.affiliation: Department of Dermatology, Ed Herriot Hospital Group, Lyon, France.
authors.forename: Jean
authors.initials: J
authors.lastname: Kanitakis
authors.affiliation: Division of Dermatology, San Gallicano Dermatological Institute, Rome, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Latini
authors.affiliation: Dermatopathology Unit, San Gallicano Dermatological Institute, Rome, Italy. Electronic address: carlocota@yahoo.it.
authors.forename: Carlo
authors.initials: C
authors.lastname: Cota
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology*; D000068800:Etanercept; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007150:Immunohistochemistry; D008010:Lichen Planus / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology*; D035583:Rare Diseases; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept